Cancers, Vol. 11, Pages 1187: 4-Methylumbelliferone Inhibits Cancer Stem Cell Activation and Overcomes Chemoresistance in Ovarian Cancer
Cancers, Vol. 11, Pages 1187: 4-Methylumbelliferone Inhibits Cancer Stem Cell Activation and Overcomes Chemoresistance in Ovarian Cancer
Cancers doi: 10.3390/cancers11081187
Authors:
Noor A. Lokman
Zoe K. Price
Emily K. Hawkins
Anne M. Macpherson
Martin K. Oehler
Carmela Ricciardelli
We have recently shown that the extracellular matrix molecule hyaluronan (HA) plays a role in the development of ovarian cancer chemoresistance. This present study determined if HA production is increased in chemotherapy-resistant ovarian cancers and if the HA inhibitor 4-methylubelliferone (4-MU) can overcome chemoresistance to the chemotherapeutic drug carboplatin (CBP) and inhibit spheroid formation and the expression of cancer stem cell (CSC) markers. We additionally assessed whether 4-MU could inhibit in vivo invasion of chemoresistant primary ovarian cancer cells in the chicken embryo chorioallantoic membrane (CAM) assay. The expression of the HA synthases HAS2 and HAS3 was significantly increased in chemoresistant compared to chemosensitive primary ovarian cancer cells isolated from patient ascites. 4-MU significantly inhibited HA production, cell survival, and spheroid formation of chemoresistant serous ovarian cancer cells. In combination with CBP, 4-MU treatment significantly decreased ovarian cancer cell survival and increased apoptosis of chemoresistant primary cells compared to CBP alone. 4-MU significantly reduced spheroid formation, expression of CSC markers ALDH1...
Source: Cancers - Category: Cancer & Oncology Authors: Noor A. Lokman Zoe K. Price Emily K. Hawkins Anne M. Macpherson Martin K. Oehler Carmela Ricciardelli Tags: Article Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Ovarian Cancer | Ovaries | Stem Cell Therapy | Stem Cells | Study